Newsroom2021-01-13T08:26:53-05:00

Newsroom – Important Announcements and Information Regarding Cosette Pharma

20Oct. 2021

Mindy Hanna has joined Cosette Pharmaceuticals as Senior Director, Human Resources

We are pleased to announce Mindy Hanna has joined Cosette Pharmaceuticals as Senior Director, Human Resources.  Mindy will report to Apurva Saraf and will be based in the South Plainfield office.   In this vital role, Mindy will provide leadership and direction on all aspects of the Human Resources function, including talent acquisition, total rewards, performance management, employee engagement and HR strategy implementation. She will work closely with the Senior Leadership Team to ensure Cosette continues to build a culture that attracts, retains and develops the best team.   Mindy has more than 25 years’ experience in human resources and joins us from Dr. Reddy’s Laboratories where she was a Senior Director, Human Resources & Talent Solutions. She led a [...]

6Oct. 2021

Solaris Pharma Receives Approval for First Generic Version of Clindagel® (clindamycin phosphate EQ 1%)

BRIDGEWATER, N.J., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Solaris Pharma Corporation (“Solaris” or the “Company”) announced today that the Company has received an abbreviated new drug application (“ANDA”) approval from the U.S. Food and Drug Administration (“FDA” or “Agency”) for the first generic version of Clindagel® (clindamycin phosphate EQ 1%). This product will be manufactured in the United States by Cosette, Solaris’ manufacturing partner. The product will be launched immediately. Clindamycin phosphate EQ 1% topical gel is the generic version of Clindagel, a registered trademark of Bausch Health. According to IQVIA™ data, U.S. annual sales for clindamycin topical gel for the 12 months ending June 2021 were approximately $31 million. “Solaris is pleased to provide patients access to this [...]

4Mar. 2021

Cosette Pharmaceuticals, Inc. Announces FDA Approval of ANDA for Hydrocortisone Valerate Cream USP, 0.2%

Bridgewater, NJ (March 04, 2021) – Cosette Pharmaceuticals, Inc., a New Jersey-based specialty generic pharmaceutical company, has received a first cycle approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) of Hydrocortisone Valerate Cream USP, 0.2%. This is Cosette’s first approval for 2021 from its internally-developed pipeline of prescription pharmaceutical products. “I am excited about our most recent approval,’’ commented Apurva Saraf, President and CEO of the Company. “This approval is further validation of Cosette’s R&D and regulatory capabilities to develop, file and receive approvals for complex products. We remain relentlessly focused on developing and launching these essential and  affordable medicines for the patients we serve.” Mr. Saraf continued, “We now have 42 pharmaceutical [...]

14Jul. 2020

Cosette Pharmaceuticals Appoints Seasoned Industry Executive Apurva Saraf as President and Chief Executive Officer

Bridgewater, NJ (July 14, 2020) – “We are very pleased to welcome Apurva to the Cosette team. His deep knowledge of the pharmaceutical industry, along with his corporate strategy and business development experience, will be of great value as Cosette continues to expand its portfolio of differentiated complex products, both internally and through strategic collaborations,” stated Sriram Venkataraman, Partner of Avista Capital Partners. “We are proud of Cosette’s unique corporate culture, consumer-centric focus, and emphasis on high-quality products and believe that Apurva will be the ideal leader to drive the next phase of the Company’s growth,” concluded Venkataraman. “I am excited for the opportunity to contribute to Cosette’s growth and build upon its impressive portfolio of products. I look [...]

3Jul. 2020

Donation to First Baptist Children’s Ministry

Bridgewater, NJ (July 3, 2020) – As a means of preventing the spread of Covid-19, Cosette Pharmaceuticals has donated bottles of hand sanitizers to First Baptist Children’s Ministry in order to keep students and teachers safe while at the center. About Cosette Pharmaceuticals, Inc. Cosette Pharmaceuticals, Inc. is a generic pharmaceutical company specializing in the areas of dermatology and allergy, with products available in dosage forms such as creams, ointments, lotions, solutions, gels, pastes and suppositories. The company was formed when Avista Capital Partners, a leading private equity firm focused on growth-oriented healthcare businesses, purchased the extended topicals and dermatology portfolio of G&W Laboratories in December 2018.  Cosette is expanding its product offering by bringing new products to market [...]

20Jun. 2020

The Impact of Giving

Bridgewater, NJ (June 20, 2020) – Just months after launching the COVID-19 Support Fund for Morristown Medical Center, community members — gave more than $3 million to purchase much-needed equipment for critical care patients, Donations also included personal protective equipment (PPE) – in bulk and individual, homemade masks – and vital medical supplies, as well as staff meals, which are still pouring into the hospital every day. Cosette Pharmaceuticals as a kind gift distributed 5,000 Units of hand sanitizers. Published at https://f4mmc.org/1-Million-for-Morristown.aspx About Cosette Pharmaceuticals, Inc. Cosette Pharmaceuticals, Inc. is a generic pharmaceutical company specializing in the areas of dermatology and allergy, with products available in dosage forms such as creams, ointments, lotions, solutions, gels, pastes and suppositories. The [...]